Global Rheumatology Arthritis Therapeutics Industry

Global Rheumatology Arthritis Therapeutics Industry Research & Trends Analysis Report

Global Rheumatology Arthritis Therapeutics Industry

Global Rheumatology Arthritis Therapeutics Industry Research & Trends Analysis Report


Get latest Market Research Reports on Rheumatology Arthritis Therapeutics. Industry analysis and Market Report on Rheumatology Arthritis Therapeutics is a syndicated market report, published as Global Rheumatology Arthritis Therapeutics Market Research Report . It is complete Research Study and Industry Analysis of Rheumatology Arthritis Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to Market IntelliX Research, the global market for Rheumatology Arthritis Therapeutics should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Rheumatology Arthritis Therapeutics market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Rheumatology Arthritis Therapeutics market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Topical segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Hospitals has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.

The global key manufacturers of Rheumatology Arthritis Therapeutics include AbbVie, Boehringer Ingelheim GmbH, Novartis AG, Regeneron Pharmaceuticals, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., UCB S.A. and Johnson & Johnson Services, Inc., etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Rheumatology Arthritis Therapeutics. Report Highlights:

(1) Global Rheumatology Arthritis Therapeutics market size (value),history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Rheumatology Arthritis Therapeutics market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Rheumatology Arthritis Therapeutics market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Rheumatology Arthritis Therapeutics segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Rheumatology Arthritis Therapeutics segment by type and by application and regional segment by type and by application.

(6) Rheumatology Arthritis Therapeutics industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Topical

Oral

Parenteral

Market segment by application, can be divided into

Hospitals

Clinics

Others

Market segment by players, this report covers

AbbVie

Boehringer Ingelheim GmbH

Novartis AG

Regeneron Pharmaceuticals, Inc.

Pfizer, Inc.

Bristol-Myers Squibb Company

F. Hoffmann-La Roche Ltd.

UCB S.A.

Johnson & Johnson Services, Inc.

Amgen, Inc.

1 Market Overview

1.1 Product Overview and Scope of Rheumatology Arthritis Therapeutics

1.2 Global Rheumatology Arthritis Therapeutics Market Size and Forecast

1.3 China Rheumatology Arthritis Therapeutics Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Rheumatology Arthritis Therapeutics Share in Global Market, 2019-2030

1.4.2 Rheumatology Arthritis Therapeutics Market Size: China VS Global, 2019-2030

1.5 Rheumatology Arthritis Therapeutics Market Dynamics

1.5.1 Rheumatology Arthritis Therapeutics Market Drivers

1.5.2 Rheumatology Arthritis Therapeutics Market Restraints

1.5.3 Rheumatology Arthritis Therapeutics Industry Trends

1.5.4 Rheumatology Arthritis Therapeutics Industry Policy

2 Global Competitive Situation by Company

2.1 Global Rheumatology Arthritis Therapeutics Revenue by Company (2019-2024)

2.2 Global Rheumatology Arthritis Therapeutics Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Rheumatology Arthritis Therapeutics Concentration Ratio

2.4 Global Rheumatology Arthritis Therapeutics Mergers & Acquisitions, Expansion Plans

2.5 Global Rheumatology Arthritis Therapeutics Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Rheumatology Arthritis Therapeutics Revenue by Company (2019-2024)

3.2 China Rheumatology Arthritis Therapeutics Rheumatology Arthritis Therapeutics Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Rheumatology Arthritis Therapeutics, Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)

4 Industry Chain Analysis

4.1 Rheumatology Arthritis Therapeutics Industry Chain

4.2 Rheumatology Arthritis Therapeutics Upstream Analysis

4.3 Rheumatology Arthritis Therapeutics Midstream Analysis

4.4 Rheumatology Arthritis Therapeutics Downstream Analysis

5 Sights by Type

5.1 Rheumatology Arthritis Therapeutics Classification

5.1.1 Topical

5.1.2 Oral

5.1.3 Parenteral

5.2 By Type, Global Rheumatology Arthritis Therapeutics Market Size & CAGR, 2019 VS 2024 VS 2030

5.3 By Type, Global Rheumatology Arthritis Therapeutics Revenue, 2019-2030

6 Sights by Application

6.1 Rheumatology Arthritis Therapeutics Segment by Application

6.1.1 Hospitals

6.1.2 Clinics

6.1.3 Others

6.2 By Application, Global Rheumatology Arthritis Therapeutics Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Application, Global Rheumatology Arthritis Therapeutics Revenue, 2019-2030

7 Sales Sights by Region

7.1 By Region, Global Rheumatology Arthritis Therapeutics Market Size, 2019 VS 2024 VS 2030

7.2 By Region, Global Rheumatology Arthritis Therapeutics Market Size, 2019-2030

7.3 North America

7.3.1 North America Rheumatology Arthritis Therapeutics Market Size & Forecasts, 2019-2030

7.3.2 By Country, North America Rheumatology Arthritis Therapeutics Market Size Market Share

7.4 Europe

7.4.1 Europe Rheumatology Arthritis Therapeutics Market Size & Forecasts, 2019-2030

7.4.2 By Country, Europe Rheumatology Arthritis Therapeutics Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Rheumatology Arthritis Therapeutics Market Size & Forecasts, 2019-2030

7.5.2 By Country/Region, Asia Pacific Rheumatology Arthritis Therapeutics Market Size Market Share

7.6 South America

7.6.1 South America Rheumatology Arthritis Therapeutics Market Size & Forecasts, 2019-2030

7.6.2 By Country, South America Rheumatology Arthritis Therapeutics Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Rheumatology Arthritis Therapeutics Market Size & CAGR，2019 VS 2024 VS 2030

8.2 By Country, Global Rheumatology Arthritis Therapeutics Market Size, 2019-2030

8.3 U.S.

8.3.1 U.S. Rheumatology Arthritis Therapeutics Market Size, 2019-2030

8.3.2 By Company, U.S. Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2024

8.3.3 By Type, U.S. Rheumatology Arthritis Therapeutics Revenue Market Share, 2023 VS 2030

8.3.4 By Application, U.S. Rheumatology Arthritis Therapeutics Revenue Market Share, 2023 VS 2030

8.4 Europe

8.4.1 Europe Rheumatology Arthritis Therapeutics Market Size, 2019-2030

8.4.2 By Company, Europe Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2024

8.4.3 By Type, Europe Rheumatology Arthritis Therapeutics Revenue Market Share, 2023 VS 2030

8.4.4 By Application, Europe Rheumatology Arthritis Therapeutics Revenue Market Share, 2023 VS 2030

8.5 China

8.5.1 China Rheumatology Arthritis Therapeutics Market Size, 2019-2030

8.5.2 By Company, China Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2024

8.5.3 By Type, China Rheumatology Arthritis Therapeutics Revenue Market Share, 2023 VS 2030

8.5.4 By Application, China Rheumatology Arthritis Therapeutics Revenue Market Share, 2023 VS 2030

8.6 Japan

8.6.1 Japan Rheumatology Arthritis Therapeutics Market Size, 2019-2030

8.6.2 By Company, Japan Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2024

8.6.3 By Type, Japan Rheumatology Arthritis Therapeutics Revenue Market Share, 2023 VS 2030

8.6.4 By Application, Japan Rheumatology Arthritis Therapeutics Revenue Market Share, 2023 VS 2030

8.7 South Korea

8.7.1 South Korea Rheumatology Arthritis Therapeutics Market Size, 2019-2030

8.7.2 By Company, South Korea Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2024

8.7.3 By Type, South Korea Rheumatology Arthritis Therapeutics Revenue Market Share, 2023 VS 2030

8.7.4 By Application, South Korea Rheumatology Arthritis Therapeutics Revenue Market Share, 2023 VS 2030

8.8 Southeast Asia

8.8.1 Southeast Asia Rheumatology Arthritis Therapeutics Market Size, 2019-2030

8.8.2 By Company, Southeast Asia Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2024

8.8.3 By Type, Southeast Asia Rheumatology Arthritis Therapeutics Revenue Market Share, 2023 VS 2030

8.8.4 By Application, Southeast Asia Rheumatology Arthritis Therapeutics Revenue Market Share, 2023 VS 2030

8.9 India

8.9.1 India Rheumatology Arthritis Therapeutics Market Size, 2019-2030

8.9.2 By Company, India Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2024

8.9.3 By Type, India Rheumatology Arthritis Therapeutics Revenue Market Share, 2023 VS 2030

8.9.4 By Application, India Rheumatology Arthritis Therapeutics Revenue Market Share, 2023 VS 2030

8.10 Middle East & Asia

8.10.1 Middle East & Asia Rheumatology Arthritis Therapeutics Market Size, 2019-2030

8.10.2 By Company, Middle East & Asia Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2024

8.10.3 By Type, Middle East & Asia Rheumatology Arthritis Therapeutics Revenue Market Share, 2023 VS 2030

8.10.4 By Application, Middle East & Asia Rheumatology Arthritis Therapeutics Revenue Market Share, 2023 VS 2030

9 Global Manufacturers Profile

9.1 AbbVie

9.1.1 AbbVie Company Information, Head Office, Market Area and Industry Position

9.1.2 AbbVie Company Profile and Main Business

9.1.3 AbbVie Rheumatology Arthritis Therapeutics Models, Specifications and Application

9.1.4 AbbVie Rheumatology Arthritis Therapeutics Revenue and Gross Margin, 2019-2024

9.1.5 AbbVie Recent Developments

9.2 Boehringer Ingelheim GmbH

9.2.1 Boehringer Ingelheim GmbH Company Information, Head Office, Market Area and Industry Position

9.2.2 Boehringer Ingelheim GmbH Company Profile and Main Business

9.2.3 Boehringer Ingelheim GmbH Rheumatology Arthritis Therapeutics Models, Specifications and Application

9.2.4 Boehringer Ingelheim GmbH Rheumatology Arthritis Therapeutics Revenue and Gross Margin, 2019-2024

9.2.5 Boehringer Ingelheim GmbH Recent Developments

9.3 Novartis AG

9.3.1 Novartis AG Company Information, Head Office, Market Area and Industry Position

9.3.2 Novartis AG Company Profile and Main Business

9.3.3 Novartis AG Rheumatology Arthritis Therapeutics Models, Specifications and Application

9.3.4 Novartis AG Rheumatology Arthritis Therapeutics Revenue and Gross Margin, 2019-2024

9.3.5 Novartis AG Recent Developments

9.4 Regeneron Pharmaceuticals, Inc.

9.4.1 Regeneron Pharmaceuticals, Inc. Company Information, Head Office, Market Area and Industry Position

9.4.2 Regeneron Pharmaceuticals, Inc. Company Profile and Main Business

9.4.3 Regeneron Pharmaceuticals, Inc. Rheumatology Arthritis Therapeutics Models, Specifications and Application

9.4.4 Regeneron Pharmaceuticals, Inc. Rheumatology Arthritis Therapeutics Revenue and Gross Margin, 2019-2024

9.4.5 Regeneron Pharmaceuticals, Inc. Recent Developments

9.5 Pfizer, Inc.

9.5.1 Pfizer, Inc. Company Information, Head Office, Market Area and Industry Position

9.5.2 Pfizer, Inc. Company Profile and Main Business

9.5.3 Pfizer, Inc. Rheumatology Arthritis Therapeutics Models, Specifications and Application

9.5.4 Pfizer, Inc. Rheumatology Arthritis Therapeutics Revenue and Gross Margin, 2019-2024

9.5.5 Pfizer, Inc. Recent Developments

9.6 Bristol-Myers Squibb Company

9.6.1 Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position

9.6.2 Bristol-Myers Squibb Company Company Profile and Main Business

9.6.3 Bristol-Myers Squibb Company Rheumatology Arthritis Therapeutics Models, Specifications and Application

9.6.4 Bristol-Myers Squibb Company Rheumatology Arthritis Therapeutics Revenue and Gross Margin, 2019-2024

9.6.5 Bristol-Myers Squibb Company Recent Developments

9.7 F. Hoffmann-La Roche Ltd.

9.7.1 F. Hoffmann-La Roche Ltd. Company Information, Head Office, Market Area and Industry Position

9.7.2 F. Hoffmann-La Roche Ltd. Company Profile and Main Business

9.7.3 F. Hoffmann-La Roche Ltd. Rheumatology Arthritis Therapeutics Models, Specifications and Application

9.7.4 F. Hoffmann-La Roche Ltd. Rheumatology Arthritis Therapeutics Revenue and Gross Margin, 2019-2024

9.7.5 F. Hoffmann-La Roche Ltd. Recent Developments

9.8 UCB S.A.

9.8.1 UCB S.A. Company Information, Head Office, Market Area and Industry Position

9.8.2 UCB S.A. Company Profile and Main Business

9.8.3 UCB S.A. Rheumatology Arthritis Therapeutics Models, Specifications and Application

9.8.4 UCB S.A. Rheumatology Arthritis Therapeutics Revenue and Gross Margin, 2019-2024

9.8.5 UCB S.A. Recent Developments

9.9 Johnson & Johnson Services, Inc.

9.9.1 Johnson & Johnson Services, Inc. Company Information, Head Office, Market Area and Industry Position

9.9.2 Johnson & Johnson Services, Inc. Company Profile and Main Business

9.9.3 Johnson & Johnson Services, Inc. Rheumatology Arthritis Therapeutics Models, Specifications and Application

9.9.4 Johnson & Johnson Services, Inc. Rheumatology Arthritis Therapeutics Revenue and Gross Margin, 2019-2024

9.9.5 Johnson & Johnson Services, Inc. Recent Developments

9.10 Amgen, Inc.

9.10.1 Amgen, Inc. Company Information, Head Office, Market Area and Industry Position

9.10.2 Amgen, Inc. Company Profile and Main Business

9.10.3 Amgen, Inc. Rheumatology Arthritis Therapeutics Models, Specifications and Application

9.10.4 Amgen, Inc. Rheumatology Arthritis Therapeutics Revenue and Gross Margin, 2019-2024

9.10.5 Amgen, Inc. Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Rheumatology Arthritis Therapeutics Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
How are players chosen for the research coverage of the Rheumatology Arthritis Therapeutics Market study?
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
What is the estimated size & growth rate of the Rheumatology Arthritis Therapeutics Market?
In recent years, the Rheumatology Arthritis Therapeutics Market has grown at an incredible rate. From 2025 to 2030, the market is expected to grow at a CAGR of yy%.
What are the underlying opportunities in the Rheumatology Arthritis Therapeutics Market?
The influx of capital into the Rheumatology Arthritis Therapeutics Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
What does the future hold for the Rheumatology Arthritis Therapeutics Industry?
This latest research publication on the Rheumatology Arthritis Therapeutics Market is an in-depth market tracker that provides a comprehensive assessment of the challenges that manufacturers face in achieving new growth cycles in the current scenario.